NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT03336333,A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL,https://clinicaltrials.gov/study/NCT03336333,SEQUOIA,ACTIVE_NOT_RECRUITING,"To compare efficacy between zanubrutinib versus bendamustine and rituximab in patients with previously untreated CLL/SLL, as measured by progression free survival assess by Independent Central Review.",YES,Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma,DRUG: Zanubrutinib|DRUG: Bendamustine|DRUG: Rituximab|DRUG: Venetoclax,"Cohort 1: Progression-free Survival (PFS) as Determined by Independent Central Review (ICR), PFS is defined as the time from randomization until first documentation of progression or death from any cause, whichever occurs first, as assessed by the ICR per 2008 International Workshop on Chronic Lymphocytic Leukemia (iwCLL) guidelines with modifications for treatment-related lymphocytosis in participants with CLL and the Revised Criteria for Response for Malignant Lymphoma in participants with small lymphocytic lymphoma (SLL)., Up to approximately 3 years and 7 months (as of cut-off date of 07MAY2021)","Cohort 1: Overall Response Rate (ORR) Between Treatment Groups as Determined by ICR, ORR in Cohort 1 is defined as the percentage of participants who achieve a complete response, complete response with incomplete bone marrow recovery, partial response, or partial response with lymphocytosis, determined by the ICR., Up to 5 years|Pooled Cohort 1/1a: Overall Response Rate (ORR) Between Treatment Groups, Up to 5 years|Cohort 1: Overall Survival (OS) Between Treatment Groups as Determined by the ICR, OS in Cohort 1 is defined as the time from randomization to the date of death due to any reason., Up to 5 years|Cohort 1: Duration of Response (DOR) Between Treatment Groups as Determined by the ICR, Duration of response in Cohort 1 determined using the iwCLL criteria with modification for treatment related lymphocytosis (in participants with CLL) and the Lugano Classification for non-Hodgkin lymphoma (NHL; in participants with SLL), is defined as the time from the date that criteria for response (ie, partial response with lymphocytosis \[PR-L\] or better) are first met to the date that disease progression is objectively documented or death, whichever occurs first., Up to 5 years|Pooled Cohort 1/1a: Duration of Response (DOR) Between Treatment Groups, Up to 5 years|Cohort 1: Progression-free Survival (PFS) Between Treatment Groups Determined by Investigator Assessment (IA), PFS is defined as the time from randomization until first documentation of progression or death from any cause, whichever occurs first, as assessed by the investigator per iwCLL guidelines with modifications for treatment-related lymphocytosis in participants with CLL and the Revised Criteria for Response for Malignant Lymphoma in participants with SLL., Up to 5 years|Pooled Cohort 1/1a: Progression-free Survival (PFS) Between Treatment Groups Determined by Investigator Assessment (IA), Up to 5 years|Cohort 1: Patient-reported Outcomes as Assessed by the (European Quality Of Life 5D 5L) EQ-5D-5L Questionnaire, Up to 5 years|Cohort 1: Patient-reported Outcomes as Assessed by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) Questionnaire., Up to 5 years|Cohort 2: Overall Response Rate (ORR), Up to 5 years|Cohort 2: Progression-free Survival (PFS), Up to 5 years|Cohort 2: Duration of Response (DOR), Up to 5 years|Cohort 3: Overall Response Rate (ORR), Up to 5 years|Cohort 3: Progression-free Survival (PFS), Up to 5 years|Cohort 3: Duration of Response (DOR), Up to 5 years|Cohort 3: Rate of Undetectable Minimal Residual Disease (MRD4), Up to 5 years|Number of Participants Experiencing Adverse Events (AEs) and Serious Adverse Events (SAEs), Up to 5 years|Apparent Rate of Clearance of Zanubrutinib From Plasma (CL/F)CL/F, Predose up to 12 hours postdose|Cohort 1 Zanubrutinib Only Arms: Area-Under-Curve From Time 0 to 12 Hours Postdose (AUC0-12), Predose up to 12 hours postdose|Cohort 3: Area-Under-Curve From Time 0 to 12 Hours Postdose (AUC0-12) of Zanubrutinib, Predose up to 12 hours postdose",,BeiGene,,ALL,"ADULT, OLDER_ADULT",PHASE3,590,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,BGB-3111-304|2017-001551-31|CTR20190416,2017-10-31,2021-05-07,2026-09,2017-11-08,2023-11-07,2025-03-25,"Augusta University, Augusta, Georgia, 30912, United States|Northwestern University, Chicago, Illinois, 60611, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Research Medical Center, Kansas City, Missouri, 64132, United States|Washington University, Saint Louis, Missouri, 63110, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|Summit Medical Group, Florham Park, New Jersey, 07932, United States|Icahn School of Medicine At Mount Sinai, New York, New York, 10029, United States|Columbia University Medical Center, New York, New York, 10032, United States|University of Rochester, Rochester, New York, 14642, United States|Duke University, Durham, North Carolina, 27710, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Prairie Lakes Healthcare System, Watertown, South Dakota, 57201, United States|Tennessee Oncology, Pllc Nashville, Nashville, Tennessee, 37203, United States|Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas, 79410, United States|University of Virginia, Charlottesville, Virginia, 22903, United States|Va Puget Sound Health Care System, Seattle, Washington, 98108, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109, United States|Concord Repatriation General Hospital, Concord, New South Wales, 2139, Australia|The Tweed Valley Hospital, Cudgen, New South Wales, 2487, Australia|Calvary Mater Newcastle, Waratah, New South Wales, 2298, Australia|Westmead Hospital, Westmead, New South Wales, 2145, Australia|Icon Cancer Centre Wesley, Auchenflower, Queensland, 4066, Australia|Princess Alexandra Hospital, Brisbane, Queensland, 4102, Australia|Royal Brisbane and Womens Hospital, Herston, Queensland, 4029, Australia|Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia|The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia|Royal Hobart Hospital, Hobart, Tasmania, 7000, Australia|Box Hill Hospital, Box Hill, Victoria, 3128, Australia|Monash Health, Clayton, Victoria, 3168, Australia|St Vincents Hospital Melbourne, Fitzroy, Victoria, 3065, Australia|Peninsula Private Hospital, Frankston, Victoria, 3199, Australia|Peter Maccallum Cancer Centre, Melbourne, Victoria, 3000, Australia|Royal Perth Hospital, Perth, Western Australia, 6000, Australia|Medizinische Universitatsklinik Innsbruck, Innsbruck, 6020, Austria|Krankenhaus Der Barmherzigen Schwestern Linz, Linz, 4010, Austria|Allgemeines Krankenhaus Der Stadt Linz, Linz, 4021, Austria|Universitatsklinik Fur Innere Medizin Iii Universitatsklinikum Der Pmu Landeskrankenhaus Salzburg, Salzburg, 5020, Austria|Klinikum Wels Grieskirchen, Wels, 4600, Austria|Universitair Ziekenhuis Brussel, Brussels, 1090, Belgium|Universitair Ziekenhuis Gent, Gent, 9000, Belgium|Centre Hospitalier Universitaire (Chu) de Liege Site Du Sart Tilman, Liege, 4000, Belgium|Clinique Saint Pierre, Ottignies, 1340, Belgium|Centre Hospitalier Universitaire Universite Catholique de Louvain Site Godinne, Yvoir, 5530, Belgium|Anhui Provincial Hospital, Hefei, Anhui, 230000, China|Peking University Third Hospital, Beijing, Beijing, 100000, China|Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, 100050, China|Peking Union Medical College Hospital, Beijing, Beijing, 100730, China|Second Affiliated Hospital of Army Medical University (Xinqiao Hospital), Chongqing, Chongqing, 400037, China|Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, China|Quanzhou First Affliated Hospital of Fujian Medical University, Quanzhou, Fujian, 362000, China|Guangdong Provincial Peoples Hospital, Guangzhou, Guangdong, 510080, China|Henan Cancer Hospital, Zhengzhou, Henan, 450000, China|Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China|Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China|The First Affiliated Hospital of Soochow University Branch Shizi, Suzhou, Jiangsu, 215006, China|Wuxi Peoples Hospital, Wuxi, Jiangsu, 214023, China|The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang, Jiangxi, 330006, China|The First Hospital of Jilin University, Changchun, Jilin, 130021, China|West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China|Institute of Hematology and Hospital of Blood Disease, Tianjin, Tianjin, 300020, China|Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, 300060, China|The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China|Fakultni Nemocnice Brno, Brno, 62500, Czechia|Fakultni Nemocnice Hradec Kralove, Hradec Kralove, 50005, Czechia|Fakultni Nemocnice Olomouc, Olomouc, 77900, Czechia|Vseobecna Fakultni Nemocnice V Praze, Praha, 10000, Czechia|Centre Hospitalier Victor Dupouy Dargenteuil, Argenteuil cedex, 95107, France|Centre de Lutte Contre Le Cancer Institut Bergonie, Bordeaux, 33076, France|Chu Caen Normandie, Caen cedex, 14033, France|Centre Hospitalier Departemental de Vendee, La Roche sur Yon, 85925, France|Centre Hospitalier Le Mans, Le Mans, 72037, France|Centre Hospitalier Universitaire Limoges Chu de Limoges, Limoges Cedex, 87042, France|Institut Paoli Calmettes, Marseille, 13009, France|Centre Hospitalier Universitaire Nantes Hotel Dieu, Nantes Cedex, 44093, France|Hopital de La Pitie Salpetriere, Paris, 75013, France|Groupe Hospitalier Du Haut Leveque, Pessac Cedex, 33604, France|Chu Hopital Lyon Sud, PierreBenite, 69495, France|Centre Hospitalier Universitaire de Poitier Hopital de La Miletrie Hopital Jean Bernard, Poitiers, 86000, France|Hopital Robert Debre, Reims Cedex, 51056, France|Hopital Pontchaillou, Rennes Cedex, 35033, France|Centre Henri Becquerel, Rouen Cedex, 76038, France|Chu Tours Hopital Bretonneau Service Pneumologie, Tours, 37000, France|Chu Nancy Hopital Brabois, VandoeuvrelesNancy, 54511, France|Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia, Brescia, 25123, Italy|Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori Irst, Meldola, 47014, Italy|Fondazione Irccs Ca Granda Ospedale Maggiore Policlinico, Milano, 20122, Italy|Ospedale San Raffaele, Milano, 20132, Italy|Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milano, 20162, Italy|Universita Degli Studi Di Modena Azienda Ospedaliere Policlinco, Modena, 41124, Italy|Azienda Unita Sanitaria Locale Di Ravenna, Ravenna, 48121, Italy|Universita Degli Studi La Sapienza, Roma, 00161, Italy|Fondazione Policlinico Universitario Agostino Gemelli, Roma, 00168, Italy|Azienda Ospedaliera S Maria Di Terni, Terni, 05100, Italy|Ao Citta Della Salute E Della Scienza Di Torino Presidio O, Torino, 10126, Italy|Auckland City Hospital, Auckland, 1023, New Zealand|Christchurch Hospital, Christchurch, 8011, New Zealand|Palmerston North Hospital, Palmerston North, 4442, New Zealand|North Shore Hospital, Takapuna, 0622, New Zealand|Tauranga Hospital, Tauranga, 3112, New Zealand|Szpital Specjalist W Brzozowie,Podkarpacki Osrodek Onkologiczny, Brzozow, 36-200, Poland|Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespol Szpitali Miejskich, Chorzow, 41-500, Poland|Copernicus Podmiot Leczniczy Sp Z Oo Wojewodzkie Centrum Onkologii, Gdansk, 80-219, Poland|Szpitale Pomorskie Spolka Z Ograniczona Odpowiedzialnoscia, Gdynia, 81-519, Poland|Centrum Onkologii Instytut Im Marii Sklodowskiej Curie, Oddzial W Gliwicach, Gliwice, 44-101, Poland|Malopolskie Centrum Medyczne Sc, Krakow, 30-510, Poland|Wojewodzki Szpital Specjalistyczny W Legnicy, Legnica, 59-220, Poland|Wielospecjalistyczne Centrum Onkologii I Traumatologii Im M Kopernika W Lodzi, Lodz, 93-510, Poland|Centrum Onkologii Ziemi Lubelskiej, Lublin, 20-090, Poland|Kaluga Regional Hospital, Kaluga, Kaluzhskaya Oblast', 248000, Russian Federation|State Healthcare Institution Oncologic Dispensary No Health Department of Krasnodar Region, Sochi, Krasnodarskiy Kray, 354057, Russian Federation|N N Blokhin Russian Cancer Research Center Konstantin Laktionov, Moscow, Moskva, 115478, Russian Federation|Russian Academy of Advanced Medical Studies, City Clinical Hospital, Moscow, Moskva, 115478, Russian Federation|Nizhniy Novgorod Regional Clinical Hospital Nasemashko, Nizhniy Novgorod, Nizhegorodskaya Oblast', 603126, Russian Federation|State Budgetary Healthcare Institution Regional Clinical Dispensary, Penza, Penzenskaya Oblast', 440071, Russian Federation|State Budgetary Healthcare Institution of Perm Krai Clinical Medical Sanitary Establishment, Perm, Permskiy Kray, 614077, Russian Federation|Kemerovo Regional Clinical Hospital Na Sv Belyaev, Kemerovo, Pskovskaya Oblast', 650066, Russian Federation|Ryazan Regional Clinical Hospital, Ryazan, Ryazanskaya Oblast', 390039, Russian Federation|Fgu Russian Scientific Research Institute of Hematology and Transfusiology, Saint Petersburg, Sankt-Peterburg, 191024, Russian Federation|Sverdlovsk Regional Clinical Hospital, Ekaterinburg, Sverdlovskaya Oblast', 620102, Russian Federation|Central City Hospital, Yekaterinburg, Sverdlovskaya Oblast', 620137, Russian Federation|Clinical Oncology Dispensary, Kazan, Tambovskaya Oblast', 420029, Russian Federation|Tula Area Clinical Hospital, Tula, Tul'skaya Oblast', 300053, Russian Federation|State Budgetary Healthcare Institution Volgograd Regional Clinical Oncology Dispensary, Volgograd, Volgogradskaya Oblast', 400138, Russian Federation|Hospital Universitari Germans Trias I Pujol, Badalona, 08916, Spain|Hospital Del Mar, Barcelona, 08003, Spain|Institut Catala Doncologia, Barcelona, 08908, Spain|Hospital de La Princesa, Madrid, 28006, Spain|Clinica Universidad de Navarra, Madrid, 28027, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, 28222, Spain|Clinica Universidad de Navarra Pamplona, Pamplona, 31008, Spain|Hospital Universitari I Politecnic La Fe, Valencia, 46026, Spain|Hospital de Dia Quironsalud Zaragoza, Zaragoza, 50009, Spain|Medicinkliniken, Boras, 501 82, Sweden|Sahlgrenska Universitetssjukhuset, Goteborg, 416 85, Sweden|Skanes Universitetssjukhus I Lund, Lund, 221 85, Sweden|Universitetssjukhuset Orebro, Orebro, 701 85, Sweden|Karolinska Universitetssjukhuset Solna, Stockholm, 171 76, Sweden|Uppsala Akademiska Sjukhus, Uppsala, 75185, Sweden|Hualien Tzu Chi Hospital, Hualien, 970, Taiwan|Taipei Medical University Shuang Ho Hospital, New Taipei City, 23561, Taiwan|National Taiwan University Hospital East Campus, Taipei, 100225, Taiwan|Birmingham Heartlands Hospital, Birmingham, B9 5SS, United Kingdom|The Royal Bournemouth and Christchurch Hospitals Nhs Foundation, Bournemouth, BH7 7DW, United Kingdom|Cambridge University Hospitals Nhs Foundation Trust, Cambridge, CB2 0QQ, United Kingdom|Kent and Canterbury Hospital, Canterbury, CT1 3NG, United Kingdom|The Christie Hospital, Greater Manchester, M20 4BX, United Kingdom|The Leeds Teaching Hospitals Nhs Trust, Leeds, LS9 7TF, United Kingdom|Barts and the London Nhs Trust, London, EC1M 6BQ, United Kingdom|Royal Marsden Hospital, London, SW3 6JJ, United Kingdom|Sarah Cannon Research Institute Uk, London, W1G 6AD, United Kingdom|Maidstone and Tunbridge Wells Nhs Trust, Kent Oncology Centre, Maidstone Hospital, Maidstone, ME16 9QQ, United Kingdom|Norfolk and Norwich University Hospitals Nhs Foundation Trust, Norwich, NR4 7UY, United Kingdom|Nottingham University Hospitals Nhs Trust, Nottingham, NG51PB, United Kingdom|Derriford Hospital, Plymouth, PL6 8DH, United Kingdom|Southampton General Hospital, Southampton, SO16 6YD, United Kingdom|Sunderland Royal Hospital, Sunderland, SR4 7TP, United Kingdom|The Royal Wolverhampton Nhs Trust, Wolverhampton, WV10 0QP, United Kingdom","Study Protocol, https://cdn.clinicaltrials.gov/large-docs/33/NCT03336333/Prot_000.pdf|Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/33/NCT03336333/SAP_001.pdf"
